Developed to promote the optimal expansion of human hematopoietic stem cells (HSC) from bone marrow, mobilized peripheral blood, and cord blood, Stemline Hematopoietic Stem Cell Expansion Medium demonstrates higher total nucleated cell (TNC) fold increases than other commercially available serum-free media formulations. Additionally, colony-forming unit (CFU) assays indicate that CD34+ hematopoietic stem cells grown in Stemline media demonstrate significantly greater expansion of bother early (HPP-CFC) and late (GM-CFC) progenitor populations when compared to those grown in alternative media. Human cord blood cells expanded in Stemline Media demonstrate impressive self-revewal when transplanted into immunodeficient NOC/SCID mice, illustrating Stemline′s utility in true functional trial.

Stemline Hematopoietic Stem Cell Expansion Medium free of serum and all other animal-derived components with the exception of human serum albumin and cholesterol. This exclusion increases performance consistency and elimates safety risks associated with potential adventitious agents.

Produced in a GMP state-of-the-art facility, Stemline Hematopoietic Stem Cell Expansion Medium is clearly an excellent choice for your HSC applications.

Intended for the expansion of CD 34+ progenitors derived from bone marrow, mobilized peripheral blood and cord blood.

Must be supplemented with growth factors and cytokines according to individual user protocols.

Stemline is a registered trademark of Merck KGaA, Darmstadt, Germany